Breaking News Instant updates and real-time market news.

MU

Micron

$32.71

-0.47 (-1.42%)

, FDX

FedEx

$156.00

-4.88 (-3.03%)

18:37
06/25/19
06/25
18:37
06/25/19
18:37

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Micron (MU), up 8.6%... FedEx (FDX), up 0.6%. DOWN AFTER EARNINGS: AeroVironment (AVAV), down 9.7%. ALSO LOWER: Global Blood Therapeutics (GBT), down 3.7% after it announced a $200M common stock offering.

MU

Micron

$32.71

-0.47 (-1.42%)

FDX

FedEx

$156.00

-4.88 (-3.03%)

AVAV

AeroVironment

$61.41

-0.52 (-0.84%)

GBT

Global Blood Therapeutics

$62.42

-0.87 (-1.37%)

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 09

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

  • 26

    Jun

MU Micron
$32.71

-0.47 (-1.42%)

06/24/19
MZHO
06/24/19
NO CHANGE
Target $44
MZHO
Buy
Micron price target lowered to $44 from $47 at Mizuho
Mizuho analyst Vijay Rakesh said he expects weak May quarter results and August quarter guidance from Micron when the company reports on June 25, given the Huawei ban, weaker handset demand, an uncertain rebound in hyperscale demand and DRAM and NAND prices trending below previous expectations. While he keeps a Buy rating on Micron shares, Rakesh lowered his estimates and cut his price target on the stock to $44 from $47 ahead of Tuesday's report.
06/21/19
CLVD
06/21/19
NO CHANGE
CLVD
Micron estimates lowered for May quarter at Cleveland Research
Cleveland Research reduced its May quarter assumptions for Micron to below the mid-point of revenue and EPS guidance given that its checks indicate that the timing of a DRAM market turn is pushed out to the Aug quarter of 2020 and increased their conviction that NAND will continue to be oversupplied in the second half of 2019.
06/21/19
JPMS
06/21/19
NO CHANGE
Target $50
JPMS
Overweight
Micron price target lowered to $50 from $64 at JPMorgan
JPMorgan analyst Harlan Sur lowered his estimates for Micron Technology ahead of the company's fiscal Q3 results on June 25. His reduced estimates reflect the component bans to Huawei, a 13% customer in the first half of fiscal 2019, worse than anticipated DRAM pricing, and expectations of a slower recovery in back half of this year and into next year on macro uncertainty and trade tension. The analyst believes blended DRAM pricing in the March, April and May timeframe declined by ~30% versus his previously estimated 25% decline. Sur now expects Micron's fiscal Q3 revenue and earnings to be below the low-end of the prior guided range and he estimates Q4 earnings per share troughing at around 15c-25c. The "shape of the recovery" may be negatively impacted by trade tensions with potential demand destruction in consumer segments, Sur tells investors in a research note. However, with Micron shares trading near book value, the analyst believes the risk/reward is favorable for investors to take a long position. As such, he keeps an Overweight rating on the name.
06/21/19
BARD
06/21/19
NO CHANGE
Target $28
BARD
Underperform
Baird cuts Micron price target to $28 on increasing memory inventories
Baird analyst Tristan Gerra lowered his price target for Micron Technology to $28 from $32 and keeps an Underperform rating on the shares. Micron closed yesterday up 21c to $34.15. DRAM and NAND inventories have deteriorated quarter-over-quarter and are now about twice the normal levels in the supply chain, Gerra tells investors in a research note. Further, the analyst says that production cuts are "more muted" than he expected, according to his channel checks. He continues to expect the current downturn to extend "well into" 2020. As a result, Gerra cut his 2019 earnings per share estimate for Micron to $5.76 from $6.18 and 2020 estimate to $1.00 from $3.00.
FDX FedEx
$156.00

-4.88 (-3.03%)

06/11/19
FBCO
06/11/19
NO CHANGE
Target $184
FBCO
Outperform
FedEx price target lowered to $184 from $241 at Credit Suisse
Credit Suisse analyst Allison Landry lowered his price target for FedEx (FDX) to $184 from $241 in light of the deceleration in the U.S. and global macro and temporary volume and cost headwinds, including 7-day Ground and non-renewal of the Amazon (AMZN) Domestic Express contract. The analyst reiterates an Outperform rating on FedEx shares.
06/12/19
KEYB
06/12/19
NO CHANGE
Target $190
KEYB
Overweight
FedEx price target lowered to $190 from $215 at KeyBanc
KeyBanc analyst Todd Fowler lowered his price target for FedEx (FDX) to $190 from $215 ahead of Q4 to reflect trade uncertainty and some impact of the non-renewal of the U.S. domestic Express contract with Amazon (AMZN), partially offset by improved Ground margins, voluntary buyout benefits, and modest Freight contribution. The analyst reiterates an Overweight rating on the shares.
06/18/19
SPHN
06/18/19
NO CHANGE
Target $210
SPHN
Overweight
FedEx recent headlines like 'entering The Twilight Zone,' says Stephens
Stephens analyst Jack Atkins said he understands if FedEx (FDX) investors feel some headline fatigue given it seems like "entering The Twilight Zone" with news of an expansion to its Ground operating week, canceling bonuses, telling Amazon (AMZN) it wasn't interested in its U.S. Express package business and China having launched a probe all just within the last few weeks. While Atkins lowered his Q4 outlook for FedEx to reflect increased concern about global trade trends and deteriorating demand for global airfreight capacity, he also believes the bar is low and notes the stock is trading near trough valuations. Atkins keeps an Overweight rating and $210 price target on FedEx ahead of the company's Q4 report and expected FY20 guidance announcement on June 25.
06/20/19
RAJA
06/20/19
NO CHANGE
Target $200
RAJA
Outperform
FedEx price target lowered to $200 from $215 at Raymond James
Raymond James analyst Patrick Tyler Brown lowered his price target for FedEx to $200 from $215, while reiterating an Outperform rating on the shares. While the analyst appreciates that the specter of slowing economic growth in Europe and Asia could continue to drive volume headwinds over coming quarters, he continues to believe that FedEx garners a "strong and highly idiosyncratic long-term growth profile," driven, in part, by his view that the TNT acquisition will eventually prove accretive. Moreover, on the Domestic front, Brown remains optimistic in the long-term earnings power of Ground and believes Freight, underpinned by the company's dominant terminal network can continue to drive earnings growth over freight cycles.
AVAV AeroVironment
$61.41

-0.52 (-0.84%)

06/04/19
PIPR
06/04/19
NO CHANGE
Target $74
PIPR
Neutral
AeroVironment price target lowered to $74 from $79 at Piper Jaffray
Piper Jaffray analyst Troy Jensen lowered his price target for AeroVironment to $74 from $79 and reiterates a Neutral rating on the shares. The analyst expects "solid" April quarter results, but has e concerns that management will provide fiscal 2020 guidance slightly below consensus expectations, which he believes could pressure the stock. He lowered his revenue and earnings estimates to get more in line with consensus expectations.
05/14/19
ADAM
05/14/19
UPGRADE
Target $86
ADAM
Buy
AeroVironment upgraded to Buy from Hold at Canaccord
Canaccord analyst Ken Herbert upgraded AeroVironment to Buy from Hold and raised his price target to $86 from $84, saying that while investors continue to struggle with fiscal 2020 visibility, he is encouraged by many of the recent announcements and potential opportunity in high-altitude pseudo-satellites, tactile missile systems and the international unmanned aircraft systems market. While AeroVironment would like to be viewed relative to a broader set of tech peers, the comparison to other small-cap defense growth stocks supports upside to the stock, Herbert tells investors in a research note, adding that potential M&A would be a positive catalyst as well.
05/14/19
ADAM
05/14/19
UPGRADE
ADAM
Buy
AeroVironment upgraded to Buy from Hold at Canaccord
06/11/19
PIPR
06/11/19
NO CHANGE
PIPR
Piper Jaffray views AeroVironment acquisition of Pulse 'favorably'
Piper Jaffray analyst Troy Jensen maintained a Neutral rating and $74 target on AeroVironment after it acquired Pulse Aerospace. Jensen believes the company paid "roughly 2x sales" to acquire Pulse and he views the acquisition "favorably as it complements AeroVironment's current offering and is expected to be accretive to future earnings." However, the analyst kept a Neutral rating on AeroVironment as he feels the consensus estimates for FY20 are too high.
GBT Global Blood Therapeutics
$62.42

-0.87 (-1.37%)

06/14/19
HCWC
06/14/19
NO CHANGE
Target $150
HCWC
Buy
Global Blood a 'logical bolt on acquisition candidate,' says H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay believes the data this morning from Global Blood Therapeutics "continues to de-risk the story." He believes the package for voxelotor supports accelerated approval and that Global Blood is now a "logical bolt on acquisition candidate for one of the large hematology-centric franchises." He reiterates a Buy rating on the shares with a $150 price target. Chattopadhyay says that while the Street remains fixated on a lack of statistically significant benefit in vaso-occlusive crises from a study "that was not powered for such," he defers to the October 2018 FDA workshop directed at preventing end-organ damage by lowering hemolysis as a "marked evolution in the thought process at the agency."
06/14/19
PIPR
06/14/19
NO CHANGE
PIPR
Overweight
Global Blood Therapeutics selloff today overdone, says Piper Jaffray
06/14/19
PIPR
06/14/19
NO CHANGE
Target $80
PIPR
Overweight
Global Blood Therapeutics selloff today is overdone, says Piper Jaffray
Piper Jaffray analyst Danielle Brill says that after further clarification from Global Blood Therapeutics, today's Voxelotor data, particularly for vaso-occlusive crises, appear even more in-line relative to what was previously reported. As such, the analyst views today's update as a non-event and the corresponding share selloff as overdone. Global Blood's new drug application submission remains on track for the second half of 2019, Brill tells investors in an afternoon research note. She still expects accelerated approval of Voxelotor by the first half of 2020 with no FDA advisory panel meeting. Brill keeps an Overweight rating on Global Blood Therapeutics with an $80 price target. The stock in afternoon trading is down 7% to $53.42.
06/14/19
CANT
06/14/19
NO CHANGE
Target $110
CANT
Overweight
Global Blood price target raised to $110 from $96 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for Global Blood Therapeutics to $110 from $96 saying the Hope trial indicates "disease-modifying potential" of voxelotor in sickle cell disease. The analyst reiterates an Overweight rating on the shares. Global Blood in premarket trading is down 6%, or $3.22, to $54.30.

TODAY'S FREE FLY STORIES

NOVA

Sunnova Energy

$11.13

0.089 (0.81%)

21:22
08/19/19
08/19
21:22
08/19/19
21:22
Initiation
Sunnova Energy initiated at KeyBanc »

Sunnova Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SPY

SPDR S&P 500 ETF Trust

$292.31

3.52 (1.22%)

, SPX

S&P 500

$0.00

(0.00%)

20:54
08/19/19
08/19
20:54
08/19/19
20:54
Periodicals
Trump administration considering steps on economy if conditions worsen, NYT says »

White House officials…

SPY

SPDR S&P 500 ETF Trust

$292.31

3.52 (1.22%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$48.20

2.69 (5.91%)

, TJX

TJX

$51.55

0.13 (0.25%)

20:25
08/19/19
08/19
20:25
08/19/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KSS

Kohl's

$48.20

2.69 (5.91%)

TJX

TJX

$51.55

0.13 (0.25%)

MDT

Medtronic

$104.15

1.42 (1.38%)

HD

Home Depot

$207.98

4.335 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 04

    Sep

  • 09

    Sep

BHP

BHP Group

$49.12

0.31 (0.64%)

19:32
08/19/19
08/19
19:32
08/19/19
19:32
Hot Stocks
BHP Group sees China and global economic growth slowing »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

BHP

BHP Group

$49.12

0.31 (0.64%)

19:25
08/19/19
08/19
19:25
08/19/19
19:25
Earnings
BHP Group reports FY19 Net profit up 124% at $8.31B »

Reports FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

AAPL

Apple

$210.32

3.88 (1.88%)

19:09
08/19/19
08/19
19:09
08/19/19
19:09
Periodicals
Apple aims for November launch of Apple+, Bloomberg reports »

Apple is targeting a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$195.19

2.005 (1.04%)

19:04
08/19/19
08/19
19:04
08/19/19
19:04
Hot Stocks
Accenture acquires Parker Fitzgerald, terms not disclosed »

Accenture has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Oct

BIDU

Baidu

$104.28

7.63 (7.89%)

, NBRV

Nabriva Therapeutics

$2.21

-0.06 (-2.64%)

18:47
08/19/19
08/19
18:47
08/19/19
18:47
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Baidu…

BIDU

Baidu

$104.28

7.63 (7.89%)

NBRV

Nabriva Therapeutics

$2.21

-0.06 (-2.64%)

MRNA

Moderna

$13.41

0.235 (1.78%)

VSLR

Vivint Solar

$8.30

0.3 (3.75%)

FN

Fabrinet

$56.40

0.77 (1.38%)

IQ

iQIYI

$18.10

1.02 (5.97%)

MRUS

Merus

$18.46

1.75 (10.47%)

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 19

    Aug

  • 19

    Aug

  • 19

    Aug

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 04

    Sep

  • 09

    Sep

  • 12

    Sep

ET

Energy Transfer LP

$13.77

0.3 (2.23%)

18:40
08/19/19
08/19
18:40
08/19/19
18:40
Periodicals
Energy Transfer LP performing maintenance on WTG pipeline, Reuters says »

A spokeswoman for Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$210.32

3.88 (1.88%)

, SNE

Sony

$55.71

-0.01 (-0.02%)

18:20
08/19/19
08/19
18:20
08/19/19
18:20
Periodicals
Apple allocates over $6B for original TV shows and movies, FT says »

Apple (AAPL) has budgeted…

AAPL

Apple

$210.32

3.88 (1.88%)

SNE

Sony

$55.71

-0.01 (-0.02%)

NFLX

Netflix

$309.40

6.66 (2.20%)

DIS

Disney

$135.33

0.14 (0.10%)

T

AT&T

$35.40

0.42 (1.20%)

CBS

CBS

$44.21

0.38 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 05

    Sep

  • 23

    Sep

  • 23

    Oct

LGIH

LGI Homes

$78.56

3.36 (4.47%)

18:01
08/19/19
08/19
18:01
08/19/19
18:01
Hot Stocks
LGI Homes opens two new communities in greater Seattle market »

LGI Homes announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,816.29

24.47 (1.37%)

18:01
08/19/19
08/19
18:01
08/19/19
18:01
Hot Stocks
Amazon.com to expand in Utah with new new fulfillment center »

Amazon.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

WMT

Walmart

$113.76

0.77 (0.68%)

18:00
08/19/19
08/19
18:00
08/19/19
18:00
Hot Stocks
Walmart to pay $100,000 to settle EEOC disability discrimination suit »

Wal-Mart Stores East, LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

X

U.S. Steel

$12.42

1.13 (10.01%)

17:58
08/19/19
08/19
17:58
08/19/19
17:58
Periodicals
U.S. Steel to lay off hundreds of workers at Great Lakes plant, Reuters says »

U.S. Steel plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

17:53
08/19/19
08/19
17:53
08/19/19
17:53
Hot Stocks
Breaking Hot Stocks news story on Sarepta »

Sarepta falls over 4% or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

17:52
08/19/19
08/19
17:52
08/19/19
17:52
Hot Stocks
FDA's CRL to Sarepta's golodirsen citing risk of infection, renal toxicity »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

BSX

Boston Scientific

$42.74

0.59 (1.40%)

17:41
08/19/19
08/19
17:41
08/19/19
17:41
Hot Stocks
Boston Scientific's ImageReady MRI labeling receives FDA approval »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

  • 13

    Nov

AMZN

Amazon.com

$1,816.29

24.47 (1.37%)

, GOOG

Alphabet

$1,198.01

21.07 (1.79%)

17:35
08/19/19
08/19
17:35
08/19/19
17:35
Periodicals
State AGs to proceed with antitrust investigation of big tech, WSJ reports »

A group of state…

AMZN

Amazon.com

$1,816.29

24.47 (1.37%)

GOOG

Alphabet

$1,198.01

21.07 (1.79%)

GOOGL

Alphabet Class A

$1,199.94

21.25 (1.80%)

FB

Facebook

$186.22

2.8 (1.53%)

MSFT

Microsoft

$138.43

2.3 (1.69%)

AAPL

Apple

$210.32

3.88 (1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

FB

Facebook

$186.22

2.8 (1.53%)

17:31
08/19/19
08/19
17:31
08/19/19
17:31
Periodicals
FTC head says breaking up Facebook could be complicated, FT reports »

Federal Trade Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

MPW

Medical Properties Trust

$18.28

0.13 (0.72%)

17:28
08/19/19
08/19
17:28
08/19/19
17:28
Hot Stocks
Medical Properties Trust COO sells 100K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

WMT

Walmart

$113.76

0.77 (0.68%)

17:17
08/19/19
08/19
17:17
08/19/19
17:17
Periodicals
Walmart's U.S. Chief Marketing Officer Barbara Messing is leaving, AdAge says »

Walmart U.S. Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

MAXR

Maxar Technologies

$6.49

0.185 (2.93%)

17:12
08/19/19
08/19
17:12
08/19/19
17:12
Hot Stocks
Maxar Technologies' MDA awarded Canadian Space Agency contract »

MDA, a Maxar company, has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCI

Rogers Communications

$51.30

0.21 (0.41%)

17:06
08/19/19
08/19
17:06
08/19/19
17:06
Hot Stocks
Rogers 'disappointed' by CRTC decision on broadband wholesale rates »

Rogers Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$18.10

1.02 (5.97%)

17:05
08/19/19
08/19
17:05
08/19/19
17:05
Hot Stocks
Breaking Hot Stocks news story on iQIYI »

iQIYI down over 6% or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

IQ

iQIYI

$18.10

1.02 (5.97%)

17:03
08/19/19
08/19
17:03
08/19/19
17:03
Hot Stocks
iQIYI reports Q2 total subscribing members 100.5M, up 50% from last year »

iQIYI's number of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.